Kayne Anderson Capital Advisors LP Takes Position in Danaher Corporation $DHR

Posted by Brenda Bartman on Aug 22nd, 2026

Kayne Anderson Capital Advisors LP bought a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 7,362 shares of the conglomerate’s stock, valued at approximately $5,301,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. LaSalle St. Investment Advisors LLC acquired a new position in Danaher during the second quarter worth approximately $333,000. Oxford Financial Group LTD. LLC bought a new position in shares of Danaher during the 2nd quarter worth approximately $682,000. D L Carlson Investment Group Inc. acquired a new position in shares of Danaher during the 2nd quarter worth approximately $6,800,000. Portfolio Design Labs LLC bought a new stake in Danaher in the 2nd quarter valued at $992,000. Finally, Reliant Investment Partners LLC acquired a new stake in Danaher during the 2nd quarter valued at $369,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $219.42 on Friday. The firm has a 50 day moving average of $195.80 and a 200-day moving average of $192.61. The stock has a market capitalization of $154.25 billion, a PE ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business posted $0.77 EPS. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on DHR shares. Citigroup assumed coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective on the stock. Piper Sandler initiated coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Royal Bank Of Canada boosted their price objective on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. HSBC lowered their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Finally, Guggenheim decreased their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Check Out Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Kayne Anderson Capital Advisors LP Takes Position in Danaher Corporation $DHR

Danaher Price Performance

Analyst Upgrades and Downgrades

About Danaher

Further Reading

You might be interested in: